Valliere, Meaghan A.
Korman, Tyler P.
Woodall, Nicholas B.
Khitrov, Gregory A.
Taylor, Robert E.
Baker, David https://orcid.org/0000-0001-7896-6217
Bowie, James U.
Article History
Received: 13 November 2018
Accepted: 10 January 2019
First Online: 4 February 2019
Change Date: 24 May 2019
Change Type: Correction
Change Details: In the original version of this Article, the genotype of the M30 mutant presented in Fig. 3b was given incorrectly as Y288V/A232S, and the M31 mutant was given incorrectly as M1/A232S. The correct genotype of the M30 mutant is Y288A/A232S and for M31 it is Y288V/A232S. In addition, to keep consistency in genotype formatting, the genotype of the M27 mutant should be Y288V/G286S. The errors have been corrected in both the PDF and HTML versions of the Article.
Competing interests
: T.K. and J.B. are founders of a company, Invizyne Technologies, that seeks to develop cell-free chemical production. The remaining authors declare no competing interests.